US Stock MarketDetailed Quotes

Aldeyra Therapeutics (ALDX)

Watchlist
  • 4.410
  • +0.170+4.01%
Close Jan 15 16:00 ET
  • 4.430
  • +0.020+0.45%
Pre 08:58 ET
265.32MMarket Cap-6.04P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aldeyra Therapeutics (ALDX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-50.42%8M
-43.53%10.17M
11.00%10.43M
40.48%60.12M
171.87%16.58M
68.97%16.14M
74.11%18.01M
-44.10%9.39M
-31.73%42.79M
-55.48%6.1M
Selling and administrative expenses
-30.46%2.57M
-45.24%1.66M
-6.42%3M
-10.82%11.89M
8.24%1.95M
42.78%3.7M
-10.11%3.04M
-42.34%3.21M
-13.26%13.34M
-62.00%1.8M
-General and administrative expense
-30.46%2.57M
-45.24%1.66M
-6.42%3M
-10.82%11.89M
8.24%1.95M
42.78%3.7M
-10.11%3.04M
-42.34%3.21M
-13.26%13.34M
-62.00%1.8M
Research and development costs
-56.35%5.43M
-43.18%8.51M
20.05%7.42M
63.70%48.22M
240.37%14.63M
78.71%12.44M
114.99%14.97M
-44.97%6.18M
-37.73%29.46M
-52.04%4.3M
Operating profit
50.42%-8M
43.53%-10.17M
-11.00%-10.43M
-40.48%-60.12M
-171.87%-16.58M
-68.97%-16.14M
-74.11%-18.01M
44.10%-9.39M
31.73%-42.79M
55.48%-6.1M
Net non-operating interest income expense
-69.47%312.79K
-65.40%401.42K
-62.04%497.96K
-18.78%4.27M
-42.82%769.02K
-24.86%1.02M
-14.42%1.16M
10.45%1.31M
701.34%5.25M
69.24%1.34M
Non-operating interest income
-47.55%788.69K
-46.76%872.04K
-45.78%981.49K
-15.45%6.19M
-33.31%1.24M
-20.94%1.5M
-13.01%1.64M
7.83%1.81M
211.69%7.32M
48.08%1.86M
Non-operating interest expense
-0.70%475.9K
-1.46%470.62K
-3.01%483.53K
-7.01%1.93M
-8.44%470.86K
-11.04%479.25K
-9.40%477.6K
1.47%498.53K
22.27%2.07M
11.60%514.26K
Other net income (expense)
Income before tax
49.13%-7.69M
42.03%-9.77M
-22.86%-9.93M
-48.77%-55.85M
-232.61%-15.81M
-84.60%-15.11M
-87.47%-16.85M
48.24%-8.08M
39.47%-37.54M
63.16%-4.75M
Income tax
Net income
49.13%-7.69M
42.03%-9.77M
-22.86%-9.93M
-48.77%-55.85M
-232.61%-15.81M
-84.60%-15.11M
-87.47%-16.85M
48.24%-8.08M
39.47%-37.54M
63.16%-4.75M
Net income continuous Operations
49.13%-7.69M
42.03%-9.77M
-22.86%-9.93M
-48.77%-55.85M
-232.61%-15.81M
-84.60%-15.11M
-87.47%-16.85M
48.24%-8.08M
39.47%-37.54M
63.16%-4.75M
Minority interest income
Net income attributable to the parent company
49.13%-7.69M
42.03%-9.77M
-22.86%-9.93M
-48.77%-55.85M
-232.61%-15.81M
-84.60%-15.11M
-87.47%-16.85M
48.24%-8.08M
39.47%-37.54M
63.16%-4.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
49.13%-7.69M
42.03%-9.77M
-22.86%-9.93M
-48.77%-55.85M
-232.61%-15.81M
-84.60%-15.11M
-87.47%-16.85M
48.24%-8.08M
39.47%-37.54M
63.16%-4.75M
Basic earnings per share
48.00%-0.13
42.86%-0.16
-21.43%-0.17
-46.88%-0.94
-237.50%-0.27
-78.57%-0.25
-86.67%-0.28
48.15%-0.14
39.62%-0.64
63.64%-0.08
Diluted earnings per share
48.00%-0.13
42.86%-0.16
-21.43%-0.17
-46.88%-0.94
-237.50%-0.27
-78.57%-0.25
-86.67%-0.28
48.15%-0.14
39.62%-0.64
63.64%-0.08
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -50.42%8M-43.53%10.17M11.00%10.43M40.48%60.12M171.87%16.58M68.97%16.14M74.11%18.01M-44.10%9.39M-31.73%42.79M-55.48%6.1M
Selling and administrative expenses -30.46%2.57M-45.24%1.66M-6.42%3M-10.82%11.89M8.24%1.95M42.78%3.7M-10.11%3.04M-42.34%3.21M-13.26%13.34M-62.00%1.8M
-General and administrative expense -30.46%2.57M-45.24%1.66M-6.42%3M-10.82%11.89M8.24%1.95M42.78%3.7M-10.11%3.04M-42.34%3.21M-13.26%13.34M-62.00%1.8M
Research and development costs -56.35%5.43M-43.18%8.51M20.05%7.42M63.70%48.22M240.37%14.63M78.71%12.44M114.99%14.97M-44.97%6.18M-37.73%29.46M-52.04%4.3M
Operating profit 50.42%-8M43.53%-10.17M-11.00%-10.43M-40.48%-60.12M-171.87%-16.58M-68.97%-16.14M-74.11%-18.01M44.10%-9.39M31.73%-42.79M55.48%-6.1M
Net non-operating interest income expense -69.47%312.79K-65.40%401.42K-62.04%497.96K-18.78%4.27M-42.82%769.02K-24.86%1.02M-14.42%1.16M10.45%1.31M701.34%5.25M69.24%1.34M
Non-operating interest income -47.55%788.69K-46.76%872.04K-45.78%981.49K-15.45%6.19M-33.31%1.24M-20.94%1.5M-13.01%1.64M7.83%1.81M211.69%7.32M48.08%1.86M
Non-operating interest expense -0.70%475.9K-1.46%470.62K-3.01%483.53K-7.01%1.93M-8.44%470.86K-11.04%479.25K-9.40%477.6K1.47%498.53K22.27%2.07M11.60%514.26K
Other net income (expense)
Income before tax 49.13%-7.69M42.03%-9.77M-22.86%-9.93M-48.77%-55.85M-232.61%-15.81M-84.60%-15.11M-87.47%-16.85M48.24%-8.08M39.47%-37.54M63.16%-4.75M
Income tax
Net income 49.13%-7.69M42.03%-9.77M-22.86%-9.93M-48.77%-55.85M-232.61%-15.81M-84.60%-15.11M-87.47%-16.85M48.24%-8.08M39.47%-37.54M63.16%-4.75M
Net income continuous Operations 49.13%-7.69M42.03%-9.77M-22.86%-9.93M-48.77%-55.85M-232.61%-15.81M-84.60%-15.11M-87.47%-16.85M48.24%-8.08M39.47%-37.54M63.16%-4.75M
Minority interest income
Net income attributable to the parent company 49.13%-7.69M42.03%-9.77M-22.86%-9.93M-48.77%-55.85M-232.61%-15.81M-84.60%-15.11M-87.47%-16.85M48.24%-8.08M39.47%-37.54M63.16%-4.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 49.13%-7.69M42.03%-9.77M-22.86%-9.93M-48.77%-55.85M-232.61%-15.81M-84.60%-15.11M-87.47%-16.85M48.24%-8.08M39.47%-37.54M63.16%-4.75M
Basic earnings per share 48.00%-0.1342.86%-0.16-21.43%-0.17-46.88%-0.94-237.50%-0.27-78.57%-0.25-86.67%-0.2848.15%-0.1439.62%-0.6463.64%-0.08
Diluted earnings per share 48.00%-0.1342.86%-0.16-21.43%-0.17-46.88%-0.94-237.50%-0.27-78.57%-0.25-86.67%-0.2848.15%-0.1439.62%-0.6463.64%-0.08
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -